Research Frontiers Incorporated — Form 10-Q Summary
Business Context and Reporting Period
Research Frontiers develops and licenses suspended particle device technology for electronically controlled light-management products, including automotive, architectural, aerospace, marine, appliance, display, and eyewear applications. The company operates as a single business segment and primarily earns licensing and royalty fee income from licensees, particularly in the automotive market.
This unaudited filing covers the three and six months ended June 30, 2021, with comparisons to the corresponding 2020 periods. The company is a smaller reporting company listed on Nasdaq under the symbol REFR. It reported 31,650,396 common shares outstanding as of August 5, 2021.
Financial Highlights
| Metric | Three Months Ended June 30 | Six Months Ended June 30 |
|---|---|---|
| Fee income | $113,937 vs. $176,113 in 2020 | $327,060 vs. $532,286 in 2020 |
| Operating loss | $(528,951) vs. $(602,581) | $(1,086,602) vs. $(1,250,167) |
| Net loss | $(527,935), or $(0.02) per share, vs. $(398,981), or $(0.01) | $(1,085,242), or $(0.03) per share, vs. $(1,023,575), or $(0.03) |
| Operating expenses | $503,078 vs. $631,963 | $1,128,674 vs. $1,452,404 |
| Research and development | $139,810 vs. $146,731 | $284,988 vs. $330,049 |
| Net investment income | $1,016 vs. $9,460 | $1,360 vs. $32,452 |
Fee income declined approximately 35% year over year in the second quarter and 39% for the first six months. The company continues to report operating and net losses; fee income did not cover operating expenses or research and development costs. A meaningful conventional profit margin is not applicable because the company has no product cost of sales and remains loss-making.
For the six months ended June 30, 2021, net cash used in operating activities was $1,386,442, compared with $1,239,647 in 2020. Cash used in investing activities was $935, while financing activities provided $86,262 from option exercises. Cash and cash equivalents declined to $3,471,590 from $4,772,705 at December 31, 2020.
At June 30, 2021, total assets were $5,185,846, total liabilities were $857,821, shareholders’ equity was $4,328,025, and working capital was approximately $4.2 million. The company reported no debt; liabilities consist primarily of operating lease obligations. The present value of operating lease liabilities was $731,307, including $174,103 classified as current.
Material Changes Versus the Prior Comparable Period
- Second-quarter fee income decreased $62,176, and six-month fee income decreased $205,226, primarily because of lower fees in automotive, aircraft, and architectural markets. Higher display-market income partly offset the declines.
- Operating expenses decreased $128,885 in the second quarter and approximately $323,732 for the first six months, primarily due to lower payroll, depreciation, and bad-debt costs.
- Research and development expense decreased $6,921 in the second quarter and approximately $45,060 for the first six months.
- Net loss increased by $128,954 in the second quarter and $61,667 for the first six months. The prior-year periods benefited from $194,140 of estimated PPP loan forgiveness income; there was no comparable income in 2021.
- Cash used in operations increased by $146,795 for the first six months, while cash declined by $1,301,115 during the period.
- Shares outstanding increased modestly due to option and warrant exercises. The company received $86,262 from exercises and issued shares during the first six months of 2021.
Guidance, Outlook, Risks, and Unusual Items
Management projects a quarterly cash-flow shortfall of approximately $400,000 to $450,000 over the next 12 months and expects existing working capital to support operations for at least 24 months. The filing states that current cash and cash equivalents are expected to fund operations until approximately mid-2023, subject to actual expenditures, operating results, and financing availability.
The company expects automotive applications to remain its largest royalty source and anticipates potential royalty growth from additional automotive and aircraft models, marine products, trains, museums, and architectural projects. These expectations are not presented as formal financial guidance and depend on commercialization by licensees and continued royalty payments.
- COVID-19 disruptions have affected overseas licensees and delayed manufacturing, potentially reducing product sales and royalties. The duration and financial impact cannot be reasonably estimated.
- The company has incurred recurring losses since inception and has not generated sufficient licensing revenue to fully fund operations. It may need to reduce expenses or seek additional equity financing; the availability and terms of such financing are uncertain.
- Royalty income is concentrated among licensees and is sensitive to automotive production volumes, OEM adoption, product configuration, pricing, exchange rates, and broader industry conditions.
- Royalty receivables were $829,865 net of a $972,202 allowance for doubtful accounts. Collectability risks remain relevant, particularly for licensees affected by the pandemic or financial distress.
- Six license agreements had remaining initial multi-year terms at June 30, 2021, with $353,000 of revenue expected to be recognized over the remaining performance periods. One initial term ends December 31, 2021, four end December 31, 2022, and one ends December 31, 2024; the company expects annual renewals.
- The company’s $202,052 PPP loan was forgiven. The filing recorded $194,140 of related forgiveness income in the 2020 comparison periods, with no 2021 forgiveness income.
- Deferred tax assets and net operating loss benefits remain fully reserved because management considers realization uncertain.
Key Facts for Investors to Verify
- Whether royalty and licensing revenue recovers from the 2021 decline, particularly in automotive applications.
- Actual cash burn relative to management’s $400,000–$450,000 quarterly shortfall estimate and the projected mid-2023 cash runway.
- Licensee commercialization, renewal status, and concentration of fee income among major licensees.
- Collection of royalty receivables and the adequacy of the $972,202 allowance for doubtful accounts.
- Potential need for additional equity financing and the resulting dilution risk, including the 1,399,991 outstanding warrants and 1,006,660 outstanding options.
- Continuing effects of COVID-19 and other disruptions on overseas manufacturing, licensee sales, and royalty payments.